‘‘(A) advanced surveillance, tracking, and 
radar imaging; 
‘‘(B) electronic support measures; 
‘‘(C) communications; 
‘‘(D) data fusion, advanced computer sys-
tems, and artificial intelligence; and 
‘‘(E) chemical, biological, radiological (in-
cluding neutron and electron), and other means 
of detection; 
‘‘(2) identify demand reduction basic and ap-
plied research needs and initiatives, in consultation 
with affected National Drug Control Program agen-
cies, including— 
‘‘(A) 
improving 
treatment 
through 
neuroscientific advances; 
‘‘(B) improving the transfer of biomedical 
research to the clinical setting; and 
‘‘(C) in consultation with the National In-
stitute of Drug Abuse and the Substance Abuse 
and Mental Health Services Administration, 
and through interagency agreements or grants, 
examining addiction and rehabilitation research 
and the application of technology to expanding 
the effectiveness and availability of drug treat-
ment; 
VerDate Aug 31 2005 
02:27 Dec 06, 2006
Jkt 059200
PO 00000
Frm 00066
Fmt 6652
Sfmt 6201
E:\BILLS\H6344.IH
H6344
ccoleman on PROD1PC71 with BILLS
‘‘(3) make a priority ranking of such needs 
identified in paragraphs (1) and (2) according to fis-
cal and technological feasibility, as part of a Na-
tional Counterdrug Research and Development Pro-
gram; 
‘‘(4) oversee and coordinate counterdrug tech-
nology initiatives with related activities of other Fed-
eral civilian and military departments; 
‘‘(5) provide support to the development and 
implementation of the national drug control per-
formance measurement system established under 
subsection (c) of section 706; and 
‘‘(6) pursuant to the authority of the Director 
of National Drug Control Policy under section 704, 
submit requests to Congress for the reprogramming 
or transfer of funds appropriated for counterdrug 
technology research and development. 
‘‘(d) LIMITATION
ON AUTHORITY.—The authority 
granted to the Director under this section shall not extend 
to the awarding of contracts, management of individual 
projects, or other operational activities.’’. 
(2) ASSISTANCE AND SUPPORT.—Subsection (e) 
of section 708, as redesignated by this section, is 
amended to read as follows: 
VerDate Aug 31 2005 
02:27 Dec 06, 2006
Jkt 059200
PO 00000
Frm 00067
Fmt 6652
Sfmt 6201
E:\BILLS\H6344.IH
H6344
ccoleman on PROD1PC71 with BILLS
‘‘(e) ASSISTANCE AND SUPPORT TO THE OFFICE OF 
NATIONAL DRUG CONTROL POLICY.—The Secretary of 
Defense, the Secretary of Homeland Security, and the 
Secretary of Health and Human Services shall, to the 
maximum extent practicable, render assistance and sup-
port to the Office and to the Director in the conduct of 
counterdrug technology assessment.’’. 
(3) TECHNOLOGY
TRANSFER
PROGRAM.—Sec-
tion 708 is amended by adding at the end the fol-
lowing: 
‘‘(f) TECHNOLOGY TRANSFER PROGRAM.— 
‘‘(1) PROGRAM.—The Chief Scientist, with the 
advice and counsel of experts from State, local, and 
tribal law enforcement agencies, shall be responsible 
to the Director for coordination and implementation 
of a counterdrug technology transfer program. 
‘‘(2) PURPOSE.—The purpose of the Tech-
nology 
Transfer 
Program 
shall 
be 
for 
the 
Counterdrug Technology Assessment Center to 
transfer technology and associated training directly 
to State, local, and tribal law enforcement agencies. 
‘‘(3) PRIORITY OF RECEIPTS.—Transfers shall 
be made in priority order based on— 
‘‘(A) the need of potential recipients for 
such technology; 
VerDate Aug 31 2005 
02:27 Dec 06, 2006
Jkt 059200
PO 00000
Frm 00068
Fmt 6652
Sfmt 6201
E:\BILLS\H6344.IH
H6344
ccoleman on PROD1PC71 with BILLS
‘‘(B) the effectiveness of the technology to 
enhance current counterdrug activities of poten-
tial recipients; and 
‘‘(C) the ability and willingness of potential 
recipients to evaluate transferred technology. 
‘‘(4) AGREEMENT
AUTHORITY.—The Director 
may enter into an agreement with the Secretary of 
Homeland Security to transfer technology with both 
counterdrug and homeland security applications to 
State, local, and tribal law enforcement agencies on 
a reimbursable basis. 
‘‘(5) REPORT.—On or before July 1 of each 
year, the Director shall submit a report to the ap-
propriate congressional committees that addresses 
the following: 
‘‘(A) The number of requests received dur-
ing the previous 12 months, including the iden-
tity of each requesting agency and the type of 
technology requested. 
‘‘(B) The number of requests fulfilled dur-
ing the previous 12 months, including the iden-
tity of each recipient agency and the type of 
technology transferred. 
‘‘(C) A summary of the criteria used in 
making the determination on what requests 
VerDate Aug 31 2005 
02:27 Dec 06, 2006
Jkt 059200
PO 00000
Frm 00069
Fmt 6652
Sfmt 6201
E:\BILLS\H6344.IH
H6344
ccoleman on PROD1PC71 with BILLS
were funded and what requests were not fund-
ed, except that such summary shall not include 
specific information on any individual requests. 
‘‘(D) A general assessment of the future 
needs of the program, based on expected 
changes in threats, expected technologies, and 
likely need from potential recipients. 
‘‘(E) An assessment of the effectiveness of 
the technologies transferred, based in part on 
the evaluations provided by the recipients, with 
a recommendation whether the technology 
should continue to be offered through the pro-
gram.’’. 
(c) ASSISTANCE FROM SECRETARY OF HOMELAND 
SECURITY.—Section 708(d) (21 U.S.C. 1707(d)) is 
amended by inserting ‘‘, the Secretary of Homeland Secu-
rity,’’ after ‘‘The Secretary of Defense’’. 
TITLE V—NATIONAL YOUTH 
MEDIA CAMPAIGN 
SEC. 501. NATIONAL YOUTH ANTI-DRUG MEDIA CAMPAIGN. 
(a) IN GENERAL.—Section 709 (21 U.S.C. 1708) is 
amended to read as follows: 
‘‘SEC. 709. NATIONAL YOUTH ANTI-DRUG MEDIA CAMPAIGN. 
‘‘(a) IN GENERAL.—The Director shall conduct a na-
tional youth anti-drug media campaign (referred to in this 
VerDate Aug 31 2005 
02:27 Dec 06, 2006
Jkt 059200
PO 00000
Frm 00070
Fmt 6652
Sfmt 6201
E:\BILLS\H6344.IH
H6344
ccoleman on PROD1PC71 with BILLS
subtitle as the ‘national media campaign’) in accordance 
with this section for the purposes of— 
‘‘(1) preventing drug abuse among young peo-
ple in the United States; 
‘‘(2) increasing awareness of adults of the im-
pact of drug abuse on young people; and 
‘‘(3) encouraging parents and other interested 
adults to discuss with young people the dangers of 
illegal drug use. 
‘‘(b) USE OF FUNDS.— 
‘‘(1) IN GENERAL.—Amounts made available to 
carry out this section for the national media cam-
paign may only be used for the following: 
‘‘(A) The purchase of media time and 
space, including the strategic planning for, and 
accounting of, such purchases. 
‘‘(B) Creative and talent costs, consistent 
with paragraph (2)(A). 
‘‘(C) Advertising production costs. 
‘‘(D) Testing and evaluation of advertising. 
‘‘(E) Evaluation of the effectiveness of the 
national media campaign. 
‘‘(F) The negotiated fees for the winning 
bidder on requests for proposals issued either 
by the Office or its designee to enter into con-
VerDate Aug 31 2005 
02:27 Dec 06, 2006
Jkt 059200
PO 00000
Frm 00071
Fmt 6652
Sfmt 6201
E:\BILLS\H6344.IH
H6344
ccoleman on PROD1PC71 with BILLS
tracts to carry out activities authorized by this 
section. 
‘‘(G) Partnerships with professional and 
civic groups, community-based organizations, 
including faith-based organizations, and govern-
ment organizations related to the national 
media campaign. 
‘‘(H) Entertainment industry outreach, 
interactive outreach, media projects and activi-
ties, public information, news media outreach, 
and corporate sponsorship and participation. 
‘‘(I) Operational and management ex-
penses. 
‘‘(2) SPECIFIC REQUIREMENTS.— 
‘‘(A) CREATIVE SERVICES.— 
‘‘(i) In using amounts for creative and 
talent costs under paragraph (1)(B), the 
Director shall use creative services donated 
at no cost to the Government (including 
creative services provided by the Partner-
ship for a Drug-Free America) wherever 
feasible and may only procure creative 
services for advertising— 
VerDate Aug 31 2005 
02:27 Dec 06, 2006
Jkt 059200
PO 00000
Frm 00072
Fmt 6652
Sfmt 6201
E:\BILLS\H6344.IH
H6344
ccoleman on PROD1PC71 with BILLS
‘‘(I) responding to high-priority 
or emergent campaign needs that can-
not timely be obtained at no cost; or 
‘‘(II) intended to reach a minor-
ity, ethnic, or other special audience 
that cannot reasonably be obtained at 
no cost; or 
‘‘(III) the Director determines 
that the Partnership for a Drug-Free 
America is unable to provide, pursu-
ant to subsection (d)(2)(B). 
‘‘(ii) Subject to the availability of ap-
propriations, no more than $1,500,000 
may be expended under this section each 
fiscal year on creative services, except that 
the Director may expend up to $2,000,000 
in a fiscal year on creative services to meet 
urgent needs of the national media cam-
paign with advance approval from the 
Committee on Appropriations of the Sen-
ate and of the House of Representatives 
upon a showing of the circumstances caus-
ing such urgent needs of the national 
media campaign. 
VerDate Aug 31 2005 
02:27 Dec 06, 2006
Jkt 059200
PO 00000
Frm 00073
Fmt 6652
Sfmt 6201
E:\BILLS\H6344.IH
H6344
ccoleman on PROD1PC71 with BILLS
‘‘(B) TESTING AND EVALUATION OF AD-
VERTISING.—In using amounts for testing and 
evaluation of advertising under paragraph 
(1)(D), the Director shall test all advertise-
ments prior to use in the national media cam-
paign to ensure that the advertisements are ef-
fective and meet industry-accepted standards. 
The Director may waive this requirement for 
advertisements using no more than 10 percent 
of the purchase of advertising time purchased 
under this section in a fiscal year and no more 
than 10 percent of the advertising space pur-
chased under this section in a fiscal year, if the 
advertisements respond to emergent and time- 
sensitive campaign needs or the advertisements 
will not be widely utilized in the national media 
campaign. 
‘‘(C) EVALUATION OF EFFECTIVENESS OF 
MEDIA CAMPAIGN.—In using amounts for the 
evaluation of the effectiveness of the national 
media campaign under paragraph (1)(E), the 
Director shall— 
‘‘(i) designate an independent entity 
to evaluate by April 20 of each year the ef-
VerDate Aug 31 2005 
02:27 Dec 06, 2006
Jkt 059200
PO 00000
Frm 00074
Fmt 6652
Sfmt 6201
E:\BILLS\H6344.IH
H6344
ccoleman on PROD1PC71 with BILLS
fectiveness of the national media campaign 
based on data from— 
‘‘(I) the Monitoring the Future 
Study published by the Department of 
Health and Human Services; 
‘‘(II) 
the 
Attitude 
Tracking 
Study published by the Partnership 
for a Drug-Free America; 
‘‘(III) the National Household 
Survey on Drug Abuse; and 
‘‘(IV) other relevant studies or 
publications, as determined by the Di-
rector, including tracking and evalua-
tion data collected according to mar-
keting and advertising industry stand-
ards; and 
‘‘(ii) ensure that the effectiveness of 
the national media campaign is evaluated 
in a manner that enables consideration of 
whether the national media campaign has 
contributed to reduction of illicit drug use 
among youth and such other measures of 
evaluation as the Director determines are 
appropriate. 
VerDate Aug 31 2005 
02:27 Dec 06, 2006
Jkt 059200
PO 00000
Frm 00075
Fmt 6652
Sfmt 6201
E:\BILLS\H6344.IH
H6344
ccoleman on PROD1PC71 with BILLS
‘‘(3) PURCHASE
OF
ADVERTISING
TIME
AND 
SPACE.—Subject to the availability of appropria-
tions, for each fiscal year, not less than 77 percent 
of the amounts appropriated under this section shall 
be used for the purchase of advertising time and 
space for the national media campaign, subject to 
the following exceptions: 
‘‘(A) In any fiscal year for which less than 
$125,000,000 is appropriated for the national 
media campaign, not less than 72 percent of 
the amounts appropriated under this section 
shall be used for the purchase of advertising 
time and space for the national media cam-
paign. 
‘‘(B) In any fiscal year for which more 
than $195,000,000 is appropriated under this 
section, not less than 82 percent shall be used 
for advertising production costs and the pur-
chase of advertising time and space for the na-
tional media campaign. 
‘‘(c) ADVERTISING.—In carrying out this section, the 
Director shall ensure that sufficient funds are allocated 
to meet the stated goals of the national media campaign. 
‘‘(d) DIVISION
OF RESPONSIBILITIES
AND FUNC-
TIONS UNDER THE PROGRAM.— 
VerDate Aug 31 2005 
02:27 Dec 06, 2006
Jkt 059200
PO 00000
Frm 00076
Fmt 6652
Sfmt 6201
E:\BILLS\H6344.IH
H6344
ccoleman on PROD1PC71 with BILLS
‘‘(1) IN GENERAL.—The Director, in consulta-
tion with the Partnership for a Drug-Free America, 
shall determine the overall purposes and strategy of 
the national media campaign. 
‘‘(2) RESPONSIBILITIES.— 
‘‘(A) DIRECTOR.—The Director shall be 
responsible for implementing a focused national 
media campaign to meet the purposes set forth 
in subsection (a), and shall approve— 
‘‘(i) the strategy of the national media 
campaign; 
‘‘(ii) all advertising and promotional 
material used in the national media cam-
paign; and 
‘‘(iii) the plan for the purchase of ad-
vertising time and space for the national 
media campaign. 
‘‘(B) THE
PARTNERSHIP
FOR
A
DRUG- 
FREE
AMERICA.—The Director shall request 
that the Partnership for a Drug-Free Amer-
ica— 
‘‘(i) develop and recommend strategies 
to achieve the goals of the national media 
campaign, including addressing national 
and local drug threats in specific regions 
VerDate Aug 31 2005 
02:27 Dec 06, 2006
Jkt 059200
PO 00000
Frm 00077
Fmt 6652
Sfmt 6201
E:\BILLS\H6344.IH
H6344
ccoleman on PROD1PC71 with BILLS
or States, such as methamphetamine and 
ecstasy; 
‘‘(ii) create all advertising to be used 
in the national media campaign, except ad-
vertisements that are— 
‘‘(I) provided by other nonprofit 
entities pursuant to subsection (f); 
‘‘(II) intended to respond to 
high-priority or emergent campaign 
needs that cannot timely be obtained 
at no cost (not including production 
costs and talent reuse payments), pro-
vided that any such advertising mate-
rial is reviewed by the Partnership for 
a Drug-Free America; 
‘‘(III) intended to reach a minor-
ity, ethnic, or other special audience 
that cannot be obtained at no cost 
(not including production costs and 
talent reuse payments), provided that 
any such advertising material is re-
viewed by the Partnership for a Drug- 
Free America; or 
‘‘(IV) any other advertisements 
that the Director determines that the 
VerDate Aug 31 2005 
02:27 Dec 06, 2006
Jkt 059200
PO 00000
Frm 00078
Fmt 6652
Sfmt 6201
E:\BILLS\H6344.IH
H6344
ccoleman on PROD1PC71 with BILLS
Partnership for a Drug-Free America 
is unable to provide or if the Director 
determines that another entity is more 
appropriate, subject to the require-
ments of subsection (b)(2)(A) . 
If the Director determines that another entity 
is more appropriate under clause (ii)(IV), the 
Director shall notify Congress, through the 
committees of jurisdiction in the House and 
Senate, in writing, not less than 30 days prior 
to contracting with a party other than the Part-
nership for a Drug-Free America . 
‘‘(C) MEDIA
BUYING
CONTRACTOR.—The 
Director shall enter into a contract with a 
media buying contractor to plan and purchase 
advertising time and space for the national 
media campaign. The media buying contractor 
shall not provide any other service or material, 
or conduct any other function or activity which 
the Director determines should be provided by 
the Partnership for a Drug-Free America. 
‘‘(e) PROHIBITIONS.—None of the amounts made 
available under subsection (b) may be obligated or ex-
pended for any of the following: 
VerDate Aug 31 2005 
02:27 Dec 06, 2006
Jkt 059200
PO 00000
Frm 00079
Fmt 6652
Sfmt 6201
E:\BILLS\H6344.IH
H6344
ccoleman on PROD1PC71 with BILLS
‘‘(1) To supplant current anti-drug community- 
based coalitions. 
‘‘(2) To supplant pro bono public service time 
donated by national and local broadcasting networks 
for other public service campaigns. 
‘‘(3) For partisan political purposes, or express 
advocacy in support of or to defeat any clearly iden-
tified candidate, clearly identified ballot initiative, or 
clearly identified legislative or regulatory proposal. 
‘‘(4) To fund advertising that features any 
elected officials, persons seeking elected office, cabi-
net level officials, or other Federal officials employed 
pursuant to section 213 of Schedule C of title 5, 
Code of Federal Regulations. 
‘‘(5) To fund advertising that does not contain 
a primary message intended to reduce or prevent il-
licit drug use. 
‘‘(6) To fund advertising containing a primary 
message intended to promote support for the media 
campaign or private sector contributions to the 
media campaign. 
‘‘(f) MATCHING REQUIREMENT.— 
‘‘(1) IN
GENERAL.—Amounts made available 
under subsection (b) for media time and space shall 
be matched by an equal amount of non-Federal 
VerDate Aug 31 2005 
02:27 Dec 06, 2006
Jkt 059200
PO 00000
Frm 00080
Fmt 6652
Sfmt 6201
E:\BILLS\H6344.IH
H6344
ccoleman on PROD1PC71 with BILLS
funds for the national media campaign, or be 
matched with in-kind contributions of the same 
value. 
‘‘(2) NO-COST MATCH ADVERTISING DIRECT RE-
LATIONSHIP REQUIREMENT.—The Director shall en-
sure that at least 70 percent of no-cost match adver-
tising provided directly relates to substance abuse 
prevention consistent with the specific purposes of 
the national media campaign, except that in any fis-
cal year in which less than $125,000,000 is appro-
priated to the national media campaign, the Director 
shall ensure that at least 85 percent of no-cost 
match advertising directly relates to substance abuse 
prevention consistent with the specific purposes of 
the national media campaign. 
‘‘(3) NO-COST
MATCH
ADVERTISING
NOT
DI-
RECTLY RELATED.—The Director shall ensure that 
no-cost match advertising that does not directly re-
late to substance abuse prevention consistent with 
the purposes of the national media campaign in-
cludes a clear anti-drug message. Such message is 
not required to be the primary message of the match 
advertising. 
‘‘(g) FINANCIAL
AND
PERFORMANCE
ACCOUNT-
ABILITY.—The Director shall cause to be performed— 
VerDate Aug 31 2005 
02:27 Dec 06, 2006
Jkt 059200
PO 00000
Frm 00081
Fmt 6652
Sfmt 6201
E:\BILLS\H6344.IH
H6344
ccoleman on PROD1PC71 with BILLS
‘‘(1) audits and reviews of costs of the national 
media campaign pursuant to section 304C of the 
Federal Property and Administrative Services Act of 
1949 (41 U.S.C. 254d); and 
‘‘(2) an audit to determine whether the costs of 
the national media campaign are allowable under 
section 306 of such Act (41 U.S.C. 256). 
‘‘(h) REPORT
TO CONGRESS.—The Director shall 
submit on an annual basis a report to Congress that de-
scribes— 
‘‘(1) the strategy of the national media cam-
paign and whether specific objectives of the media 
campaign were accomplished; 
‘‘(2) steps taken to ensure that the national 
media campaign operates in an effective and effi-
cient manner consistent with the overall strategy 
and focus of the national media campaign; 
‘‘(3) plans to purchase advertising time and 
space; 
‘‘(4) policies and practices implemented to en-
sure that Federal funds are used responsibly to pur-
chase advertising time and space and eliminate the 
potential for waste, fraud, and abuse; and 
VerDate Aug 31 2005 
02:27 Dec 06, 2006
Jkt 059200
PO 00000
Frm 00082
Fmt 6652
Sfmt 6201
E:\BILLS\H6344.IH
H6344
ccoleman on PROD1PC71 with BILLS
‘‘(5) all contracts entered into with a corpora-
tion, partnership, or individual working on behalf of 
the national media campaign. 
‘‘(i) LOCAL TARGET REQUIREMENT.—The Director 
shall, to the maximum extent feasible, use amounts made 
available under this section for media that focuses on, or 
includes specific information on, prevention or treatment 
resources for consumers within specific local areas. 
‘‘(j) PREVENTION OF MARIJUANA USE.— 
‘‘(1) FINDINGS.—The Congress finds the fol-
lowing: 
‘‘(A) 60 percent of adolescent admissions 
for drug treatment are based on marijuana use. 
‘‘(B) Potency levels of contemporary mari-
juana, particularly hydroponically grown mari-
juana, are significantly higher than in the past, 
rising from under 1 percent of THC in the mid- 
1970s to as high as 30 percent today. 
‘‘(C) Contemporary research has dem-
onstrated that youths smoking marijuana early 
in life may be up to 5 times more likely to use 
hard drugs. 
‘‘(D) Contemporary research has dem-
onstrated clear detrimental effects in adolescent 
VerDate Aug 31 2005 
02:27 Dec 06, 2006
Jkt 059200
PO 00000
Frm 00083
Fmt 6652
Sfmt 6201
E:\BILLS\H6344.IH
H6344
ccoleman on PROD1PC71 with BILLS